未来心理健康管理
市场调查报告书
商品编码
1308035

未来心理健康管理

The Future of Mental Health Management

出版日期: | 出版商: Frost & Sullivan | 英文 71 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

心理健康管理创新文化:补充现有治疗方法以提高疗效和可及性

儘管心理健康状况会缩短人们的寿命,但心理健康往往排在身体健康之后。在 COVID-19 大流行以及其他地缘政治局势和自然灾害导致焦虑和抑郁病例增加后,这种情况正在慢慢改变。随着认识的提高,新的治疗方法不断出现,可以补充现有的治疗方法以获得更好的效果。

心理健康问题很难治疗。这是因为单一症状有多种原因,包括环境和遗传因素,并以多种方式表现出来。因此,结合多种疗法可能会提供更好的结果,而不是使用单一疗法。心理治疗和药物治疗已经存在多年,但现在更先进的诊断和治疗技术正在导致远程医疗咨询、虚拟现实、人工智能/机器学习和症状管理的使用。事实证明,它对行动不便的人有益。进入诊所,包括使用可穿戴设备来检测并通知医护人员。这些先进技术有助于弥合护理差距,全天为患者提供服务,而不仅仅是在紧急情况下。研究人员还在研究生物标记物和其他诊断工具,这些工具可以超越传统的随时间监测症状的方法来检测精神状态。

精神药物领域也正在进行许多开发。通常用于改善大脑功能的精神药物无需医生处方即可获得。微生物组疗法和天然存在的物质也是其治疗潜力正在研究的领域。

该报告确定了该行业增长的挑战、促进因素和机会,以帮助确定增长预测。它还调查相关人员生态系统并确定值得注意的合併、收购和合作伙伴关係。最后,它详细介绍了相关人员和市场相关人员可用的融资情况。

目录

战略问题

  • 为什么成长如此困难?战略要务 8(TM) - 增长障碍
  • The Strategic Imperative 8(TM)
  • 三大战略要务对心理健康产业的影响
  • 增长管道引擎(TM):加速增长机会
  • 调查方法

调查范围和细分

  • 调查背景和分析范围
  • 分割
  • 其他心理健康管理技术

增长机会分析

  • 增长促进因素
  • 生长抑製剂

介绍

  • 介绍
  • COVID-19 大流行对心理健康的影响
  • 心理健康产业发展的障碍

创新生态系统

  • 心理健康障碍:简介
  • 心理健康的治疗方法
  • 基于药物的心理健康治疗干预
  • 精神分裂症研究概述
  • 焦虑症研究概述
  • 抑郁症研究概述
  • BD研究概述
  • 饮食失调、睡眠障碍、创伤后应激障碍、药物滥用 BD Research
  • 心理健康领域的未来创新
  • 健脑膳食补充剂/精神药物
  • 适合所有年龄段的远程医疗服务
  • 用于自助、冥想和正念的移动应用程序
  • 用于心理健康管理的虚拟现实、人工智能和机器学习
  • 精神健康状况的诊断和生物标誌物的开发
  • 创新生态系统概览

规定

  • 欧洲和美国的心理健康状况
  • 亚太地区 (APAC) 国家的心理健康状况
  • 亚太地区 (APAC) 国家和中东地区的心理健康状况
  • 其他国家的心理健康状况

知识产权(IP)

  • 心理健康专利格局
  • 知识产权申请分析:要点

相关人员生态系统

  • 心理健康相关企业之间的战略合作伙伴关係
  • 融资生态系统
  • 心理健康行业併购
  • 相关人员生态系统概述

充满增长机会的宇宙

  • 增长机会1:通过AI/ML/VR补充处方治疗,以获得更好的心理健康管理成果
  • 增长机会2:开发靶向处方疗法
  • 增长机会 3:基于有效性证据的心理健康应用基准测试

下一步

  • 下一步
  • 现在为何选择 Frost & Sullivan?
  • 免责声明
简介目录
Product Code: DAA7

An Innovation Culture in Mental Health Management Complements Current Therapies for Improved Efficacy and Access to Care

Mental health conditions reduce people's life expectancy-yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments emerge that can complement existing therapies for better outcomes.

Treating mental health issues is challenging because a condition may have varying causes, such as environmental and genetic factors, and different symptoms present themselves in different degrees. As a result, combining therapies-instead of using a single therapy-could result in better efficacy. Psychotherapy and medication have been long-standing treatment methods, and now more advanced techniques for diagnosis and treatment can prove beneficial for people with limited access to a clinic, like telehealth consultations or the use of virtual reality, artificial intelligence/machine learning, and the use of wearables for detecting a symptom and notifying a medical professional. These advanced technologies help serve patients throughout the day and not just during emergencies, which closes the gaps in care. Research is also underway for biomarkers and other diagnostic tools that can detect a mental health condition, surpassing the traditional technique of monitoring symptoms for a certain period.

Much development is also undergoing in the nootropic space. Nootropics, generally used to improve brain performance, are available without a medical prescription. Microbiome therapeutics and naturally available substances are another area being explored further for therapeutic benefits.

This Frost & Sullivan report identifies the challenges, drivers, and growth opportunities in this space and helps foresee its growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. Finally, the report provides a detailed account of the funding landscape for stakeholders and market players to leverage.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Mental Health Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Scope and Segmentation

  • Research Context and Scope of Analysis
  • Segmentation
  • Other Techniques for Mental Health Management

Growth Opportunity Analysis

  • Growth Drivers
  • Growth Restraints

Introduction

  • Introduction
  • The Impact of the COVID-19 Pandemic on Mental Health
  • Roadblocks to the Mental Health Industry's Development

Innovation Ecosystem

  • An Introduction to Mental Health Conditions
  • Treatment Approaches to Mental Health
  • Drug-based Therapeutic Intervention in Mental Health
  • A Snapshot of Schizophrenia Research
  • A Snapshot of Anxiety Research
  • A Snapshot of Depression Research
  • A Snapshot of BD Research
  • A Snapshot of Eating Disorder, Sleeping Disorder, PTSD, and Substance Use Research
  • Upcoming Innovations in the Field of Mental Health
  • Brain Boosting Nutraceuticals/Nootropics
  • Telehealth Services to Cater to All Age Groups
  • Self-help, Meditation, and Mindfulness Mobile Applications
  • Virtual Reality, AI and Machine Learning for Mental Health Management
  • Diagnostics and Biomarker Development for Mental Health Conditions
  • Innovation Ecosystem Summary

Regulatory

  • The Mental Health Landscape in Europe and the United States
  • The Mental Health Landscape in Select Asia-Pacific (APAC) Countries
  • The Mental Health Landscape in Select APAC Countries and the Middle East
  • The Mental Health Landscape in Other Select Countries

Intellectual Property

  • The Patent Landscape for Mental Health
  • Key Takeaways from the IP Filing Analysis

Stakeholder Ecosystem

  • Strategic Partnerships Between Mental Health-focused Companies
  • Funding Ecosystem
  • Mergers and Acquisitions in Mental Health Industry
  • Key Takeaways from the Stakeholder Ecosystem

Growth Opportunity Universe

  • Growth Opportunity 1: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes in Mental Health Management
  • Growth Opportunity 2: The Development of Targeted Prescription Treatments
  • Growth Opportunity 3: Benchmarking Mental Health Applications Based on Efficacy Evidence

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • Legal Disclaimer